These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25416065)

  • 1. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation.
    Shimshoni E; Yablecovitch D; Baram L; Dotan I; Sagi I
    Gut; 2015 Mar; 64(3):367-72. PubMed ID: 25416065
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of non-inflammatory factors in intestinal fibrosis.
    Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR
    J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular matrix in IBD: a dynamic mediator of inflammation.
    Petrey AC; de la Motte CA
    Curr Opin Gastroenterol; 2017 Jul; 33(4):234-238. PubMed ID: 28562487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease.
    Stewart DC; Berrie D; Li J; Liu X; Rickerson C; Mkoji D; Iqbal A; Tan S; Doty AL; Glover SC; Simmons CS
    PLoS One; 2018; 13(7):e0200377. PubMed ID: 29995938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wound healing and fibrosis in intestinal disease.
    Rieder F; Brenmoehl J; Leeb S; Schölmerich J; Rogler G
    Gut; 2007 Jan; 56(1):130-9. PubMed ID: 17172588
    [No Abstract]   [Full Text] [Related]  

  • 6. Intestinal Barrier Dysfunction in Human Pathology and Aging.
    César Machado MC; da Silva FP
    Curr Pharm Des; 2016; 22(30):4645-4650. PubMed ID: 27160754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.
    Latella G; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Lawrance IC
    J Crohns Colitis; 2014 Oct; 8(10):1147-65. PubMed ID: 24731838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease.
    Boissé L; Chisholm SP; Lukewich MK; Lomax AE
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):1026-33. PubMed ID: 19566829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal fibrosis in IBD--a dynamic, multifactorial process.
    Rieder F; Fiocchi C
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):228-35. PubMed ID: 19347014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
    Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
    Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease.
    Garlatti V; Lovisa S; Danese S; Vetrano S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of mast cell-nerve interactions in intestinal nociception.
    van Diest SA; Stanisor OI; Boeckxstaens GE; de Jonge WJ; van den Wijngaard RM
    Biochim Biophys Acta; 2012 Jan; 1822(1):74-84. PubMed ID: 21496484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.
    Bettenworth D; Rieder F
    Dig Dis; 2017; 35(1-2):25-31. PubMed ID: 28147352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of intestinal bacteria in human inflammatory bowel disease.
    Vanderploeg R; Panaccione R; Ghosh S; Rioux K
    Infect Dis Clin North Am; 2010 Dec; 24(4):977-93, ix. PubMed ID: 20937461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
    Yang GY; Taboada S; Liao J
    Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms.
    Becker F; Yi P; Al-Kofahi M; Ganta VC; Morris J; Alexander JS
    Lymphology; 2014 Mar; 47(1):3-27. PubMed ID: 25109166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of extracellular matrix remodelling in adipose tissue pathophysiology: relevance in the development of obesity.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Frühbeck G
    Histol Histopathol; 2012 Dec; 27(12):1515-28. PubMed ID: 23059882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary polyphenols can modulate the intestinal inflammatory response.
    Romier B; Schneider YJ; Larondelle Y; During A
    Nutr Rev; 2009 Jul; 67(7):363-78. PubMed ID: 19566597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of tissue remodeling in inflammatory bowel disease.
    Rieder F; Fiocchi C
    Dig Dis; 2013; 31(2):186-93. PubMed ID: 24030223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.